ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,687Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 1185

$798K Total Retail Price of All Prescriptions

Rank: 89 out of 1185

755 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 755 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 755 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 14,186 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LEVOTHYROXINE SODIUM 741 631 1 3
LISINOPRIL 646 551 2 4
AMLODIPINE BESYLATE 631 531 3 1
FUROSEMIDE 581 451 4 8
HYDROCHLOROTHIAZIDE 537 419 5 12
POTASSIUM CHLORIDE 488 405 6 18
METFORMIN HCL 479 342 7 9
PRAVASTATIN SODIUM 477 378 8 7
WARFARIN SODIUM 472 418 9 21
OMEPRAZOLE 424 314 10 6
METOPROLOL TARTRATE 383 328 11 10
HYDROCODONE-ACETAMINOPHEN 347 252 S3 12 2
SIMVASTATIN 287 199 13 5
SERTRALINE HCL 267 198 14 25
TRAMADOL HCL 259 220 15 16
ATENOLOL 246 220 16 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 239 200 17 14
ATORVASTATIN CALCIUM 237 173 18 11
GABAPENTIN 222 155 19 13
NEXIUM 207 155 20 19
DONEPEZIL HCL 193 181 21 32
BENAZEPRIL HCL 191 159 22 41
CITALOPRAM HBR 168 160 23 22
RANITIDINE HCL 165 123 24 17
DIGOXIN 156 156 25 67
AMLODIPINE BESYLATE-BENAZEPRIL 140 117 26 42
DIOVAN 138 125 27 37
MIRTAZAPINE 135 124 28 57
NAMENDA 132 132 29 43
CARVEDILOL 129 89 30 24
LOSARTAN POTASSIUM 126 96 31 26
ALENDRONATE SODIUM 117 115 32 40
ZOLPIDEM TARTRATE 116 87 33 15
CYMBALTA 114 65 34 44
METOPROLOL SUCCINATE 112 107 35 20
KLOR-CON 10 111 104 36 118
CRESTOR 107 75 37 23
FAMOTIDINE 104 68 38 69
LANTUS SOLOSTAR 103 61 39 104
ALLOPURINOL 103 89 39 30
ATENOLOL-CHLORTHALIDONE 99 71 41 122
GLYBURIDE 92 57 R 42 100
CLOPIDOGREL 92 85 42 31
PREDNISONE 91 68 44 33
PROMETHAZINE HCL 89 85 R 45 76
KLOR-CON M20 87 64 46 59
CLONIDINE HCL 87 56 46 47
EXFORGE 85 70 48 161
ACTOS 83 64 49 86
ALBUTEROL SULFATE 79 79 50 174
MELOXICAM 79 66 50 27
CYCLOBENZAPRINE HCL 78 45 R 52 53
TRAZODONE HCL 78 58 52 38
TAMSULOSIN HCL 75 54 54 34
DILTIAZEM 24HR ER 75 74 54 143
ISOSORBIDE MONONITRATE ER 74 55 56 48
CIPROFLOXACIN HCL 73 65 57 62
AZITHROMYCIN 73 57 57 39
COLCRYS 66 55 59 110
DIOVAN HCT 66 49 59 46
HUMALOG 66 37 59 210
GLIPIZIDE 64 56 62 56
CLOTRIMAZOLE-BETAMETHASONE 64 64 62 176
BACLOFEN 64 24 62 150
FLUTICASONE PROPIONATE 63 36 65 29
TRIAMTERENE-HCTZ 63 53 65 71
FENTANYL 63 46 S2 65 107
AMITRIPTYLINE HCL 62 38 R 68 51
JANUVIA 62 49 68 68
TEKTURNA 61 36 70 215
LOSARTAN-HYDROCHLOROTHIAZIDE 61 41 70 36
GLIPIZIDE ER 61 61 70 77
LEVOFLOXACIN 60 57 73 109
QUETIAPINE FUMARATE 59 51 74 93
PLAVIX 57 53 75 45
SPIRONOLACTONE 57 53 75 75
TRIAMCINOLONE ACETONIDE 54 47 77 130
LIPITOR 53 41 78 89
GEMFIBROZIL 52 29 79 119
PAROXETINE HCL 51 44 80 73
GLIMEPIRIDE 51 26 80 49
LANTUS 51 50 80 66
MECLIZINE HCL 50 49 83 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.